CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in CalciMedica, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +13 vs. Q1 2023
- Shares held
- 678.6K
- +678.6K vs. Q1 2023
- Total value
- $2.72M
- +$2.72M vs. Q1 2023
- New holders
- 13
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 14 | $0 | 0.00% | +14 | New |
| Bank of America Corp | 1 | $4 | 0.00% | +1 | New |
| Gradient Investments LLC | 13 | $52 | 0.00% | +13 | New |
| Wells Fargo & Company | 14 | $56 | 0.00% | +14 | New |
| UBS Group AG | 14 | $56 | 0.00% | +14 | New |
| GWM Advisors LLC | 71 | $285 | 0.00% | +71 | New |
| Morgan Stanley | 1,556 | $6.24K | 0.00% | +1,556 | New |
| Tower Research Capital LLC (TRC) | 1,882 | $7.55K | 0.00% | +1,882 | New |
| Meritage Portfolio Management | 10,000 | $40.0K | 0.00% | +10,000 | New |
| First Manhattan Co | 13,226 | $53.0K | 0.00% | +13,226 | New |
| BML Capital Management, LLC | 88,781 | $356.0K | 0.32% | +88,781 | New |
| Deerfield Management Company, L.P. (Series C) | 265,657 | $1.07M | 0.02% | +265,657 | New |
| OrbiMed Advisors LLC | 297,380 | $1.19M | 0.02% | +297,380 | New |